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Introduction 
The 2010 Global Burden of Disease has identified anxiety and depression as the 
most prevalent mental health conditions worldwide, contributing significantly to 
overall global disease burden and years lived with disability.(Ferrari et al., 2013; 
World Federation For Mental Health, 2012) In the UK, anxiety and depressive 
disorders affect approximately 15% of the adult population.(LSE and The Centre 
for Economic Performance, 2012)
Patients with psychiatric conditions have an increased risk of cardiovascular 
disease (CVD), including myocardial infarction (MI) and stroke.(De Schutter et al.,
2011; Elderon and Whooley, 2013; Hare et al., 2014; Osborn et al., 2007; Tully et 
al., 2015) Both anxiety and depression are common mental disorders, with high 
prevalence in the general population. While the relationship between severe 
mental illness and cardiovascular disease has been widely explored, there is a 
paucity of evidence around the relationship between anxiety and incident 
cardiovascular events.(Bowen et al., 2000; Chou et al., 2012; Davies and 
Allgulander, 2013; Lambiase et al., 2014; Osborn et al., 2007) The burden of CVD
and CVD risk factors is increasing rapidly amongst young, working-age adults.
(Lavie and Milani, 2006; Moran et al., 2014; Poisson et al., 2014) Since 
cardiovascular disease is the leading cause of loss of in disability adjusted life-
years (DALYs) worldwide, this represents the greatest loss for families and 
national economies. Accordingly, it is important to know whether individuals with
anxiety or depressive disorders are at risk of earlier onset of MI and stroke 
compared to individuals without these conditions.(Murray et al., 2012) 
This study aims firstly to quantify the excess risk of non-fatal stroke or MI 
Abbreviations:
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2associated with diagnosed anxiety and depressive disorders and antidepressant 
use in an unselected primary care population, and secondly, to test the 
hypothesis that cardiovascular (CV) events may have an earlier presentation in 
patients with anxiety and depressive disorders compared to those without.  We 
hypothesize that risk will be increased in patients with these psychiatric 
conditions compared to those without and that the increased risk can be further 
explained by sociodemographic and cardiovascular risk factors. This work will 
help to identify groups at higher risk for cardiovascular outcomes and potential 
areas for focusing preventive interventions. 
Methods
A prospective cohort study using patients contributing to the east London 
primary care database held by the Clinical Effectiveness Group at Queen Mary, 
University of London was undertaken. The database comprises the electronic 
health records of approximately 950,000 individuals registered with 141 general 
practices across the east London boroughs of Tower Hamlets, Newham, and City 
& Hackney, all of which use EMIS web as their clinical computer system. The 
population of east London is one of the most deprived in the UK and has high 
levels of ethnic diversity, with over 50% of the resident population of non-white 
ethnicity.(Hull et al., 2014; Tower Hamlets Council, 2013) 
The study sample included all adult patients aged 30 and over in March 2015 
who were free from MI or stroke at the start of the study period in March 2005. 
Anonymised demographic, clinical and prescribing data were extracted for all 
individuals meeting the study entry criteria. 
3Read codes are the standard clinical terminology system used in general practice
across the UK.(Chisholm, 1990) Diagnostic Read codes for anxiety and 
depressive disorders were selected by the authors, who comprised general 
practitioners, clinical psychiatrists, and epidemiologists. Diagnoses of diabetes 
mellitus, before March 2005, and MI and stroke, between March 2005 and March 
2015, were defined according the quality and outcomes framework Read code 
specifications.(NHS Employers, 2014) Individuals without a diagnostic Read code 
for each condition were considered to be free from the disease of interest.
Self-reported ethnicity was recorded at the practice during registration or routine 
consultation. Ethnic categories were based on the UK census and for this study 
were condensed into four categories: White (British, Irish, other white), Black 
(Black African, Black Caribbean, other Black) South Asian (Bangladeshi, Pakistani,
Indian, other South Asian) and any other ethnic group. Patients with mixed 
ethnicity were grouped with their parent ethnic minority. Individuals with missing 
ethnicity information were grouped into an “unknown” category (results not 
shown). Deprivation was classified using the Townsend deprivation score, a 
census-based index of material deprivation calculated by the combination of four
variables from the 2001 census: car ownership, overcrowded households, 
households not owner occupied, and unemployment.(Townsend, 1987) 
Systolic and diastolic blood pressure, total cholesterol level, tobacco 
consumption and antidepressant use closest to and before March 2005 were 
extracted to identify baseline values at study entry. Hypertension was identified 
using the clinical Read code for hypertensive disease. Obesity was defined as 
having a body mass index of 30 kg/m2 or above; Hyperlipidemia was defined as 
4having a total cholesterol value of greater than 5 mmol/L; Tobacco consumption 
was dichotomized into current smoker vs. not current smoker.  Individuals 
without Read codes for tobacco consumption were considered to be non-current 
smokers.
Individuals entered the study in March 2005 and were followed up until they 
experienced an incident non-fatal event of MI or stroke during the ten years of 
follow-up. Follow-up time was censored at the end of the study period in March 
2015 if they did not experience the outcome of interest. 
Cox proportional-hazards regression analyses were used to firstly compare the 
risk of incident MI and stroke in patients with and without depression at baseline 
and secondly to compare the risk of incident MI and stroke in patient with and 
without anxiety at baseline. Three regression models were built; The first 
adjusted for age, gender, and ethnic group, the second additionally adjusted for 
diabetes, hypertension, hyperlipidemia, and smoking antidepressant prescribing 
at baseline, obesity, and Townsend deprivation score, and the third additionally 
adjusted for the presence of co-morbid anxiety or depression. Linear regression 
models adjusting for gender and ethnicity were used to compare the age at the 
time of MI and stroke of patients with and without anxiety and depression.  All 
models accounted for clustering of patients within general practices using a 
shared frailty term for practice, which reflects the non-independence of patients 
attending the same health care provider.(Allison, 2014)
5Results  
A total of 524,952 adults aged 30 and over registered with the east London 
primary care database in March 2015 were identified. The characteristics of the 
study sample are presented in table 1. From the total population, 21,811 
individuals had an existing diagnosis of depression at baseline (4.1%) while 
22,128 had an existing diagnosis of anxiety (4.2%). Compared to individuals free 
from psychiatric disorders, individuals with depression or anxiety were older, had
a higher proportion of females and a smaller proportion of individuals from ethnic
minority groups (p<0.001). Prevalence of all clinical co-morbidities at baseline 
was higher in those with anxiety or depressive disorders, most notably 
hyperlipidemia was present in 60% of those with anxiety or depressive disorders 
and 40% of those without anxiety or depressive disorders (p<0.001). Similarly, 
40% of those with anxiety or depressive disorders were identified as current 
smokers, compared to 27% of the general population. Incidence of both MI and 
stroke was doubled for those with anxiety or depressive disorders compared to 
those without (p<0.001).
(Insert table 1 here)
As all included patients were necessarily registered in the database in March 
2015, all were able to contribute a full ten years of follow-up time to the study. 
Cumulative-hazard curves illustrating the increased cumulative incidence of MI 
and Stroke in individuals with anxiety or depression compared to those without 
are shown in figure 1.
(Insert figure 1 here)
6Cox proportional hazards models for the risk of incident non-fatal MI and stroke 
for patients with and without anxiety are presented in table 2. After adjusting for 
age, gender, and ethnic group (model 1), the risk of MI was raised by 33% in 
those with anxiety relative to those without (HR 1.33, CI95% 1.17, 1.52). After 
adjustment for baseline risk factors and deprivation in model 2, the association 
between anxiety and MI was attenuated, and association did not reach the level 
of statistical significance (HR 1.10, CI95% 0.96, 1.26).  This lack of association 
remained after, adjustment for co-morbid depression in model 3 (HR 1.08, CI95%
0.94, 1.24). An independent association between antidepressants and MI was 
observed in the analysis for anxiety (HR 1.25, CI95% 1.13, 1.39). No evidence for
a relationship between anxiety and stroke was evident in any of the survival 
analysis models (Table 2). 
(Insert table 2 here)
Cox proportional hazards models for the risk of incident non-fatal MI and stroke 
for patients with and without depressive disorders are presented in table 3. After 
adjusting for age, gender, and ethnic group in model 1, the risk of MI was raised 
by 52% in those with depressive disorders compared to those without (HR 1.52 
CI95% 1.34, 1.73). The risk of stroke was raised by 43% in those with depressive 
disorders compared to those without after adjusting for the same (HR 1.43 CI95%
1.11, 1.78). The independent effect of depressive disorders on risk of incident MI 
and stroke remained after additionally adjusting for cardiovascular risk factors, 
medication use, and deprivation in model 2 (MI HR 1.22, CI95% 1.06, 1.40, 
Stroke HR 1.29, CI95% 1.00-1.67). Finally, adjusting for the presence of anxiety 
at baseline in model 3 did not have an appreciable effect on the independent 
effect of depressive disorders on MI and stroke. As with the previous analysis, 
independent associations between antidepressants and MI were also observed in
7the analysis for depression.
(Insert table 3 here)
Multivariable analyses examining differences in age at first CVD presentation 
according to psychiatric condition showed that anxiety was associated with an 
earlier presentation of MI 3.6 years (2.1-5.0) p<0.001 and depression was 
associated with an earlier presentation of strokes 4.1 years (1.1-7.1) p=0.008. 
There were no significant associations between depression and age at time of MI,
or anxiety and age at the time of stroke (Table 4). 
(Insert table 4 here)
8Discussion 
Principal Findings
This study has used a large electronic health database to highlight the 
heterogeneity of risk of cardiovascular outcomes according to psychiatric 
disorder in an ethnically and socially diverse population. While the study 
demonstrates a strong relationship between depression and cardiovascular 
disease, the evidence for a relationship between cardiovascular disease and 
anxiety is weaker. The study shows that the mean age at first MI is lower in those
with anxiety, while mean age at first stroke is lower in those with depression. 
Furthermore, the study has shown a strong independent effect of antidepressant 
on risk of MI, but not stroke. Our findings show that traditional cardiovascular risk
factors can explain part of the association between anxiety, depression and 
cardiovascular disease. This is encouraging as the majority of these modifiable 
risk factors can be managed in primary care. The association between anxiety 
and incident MI was reduced after adjustment for cardiovascular risk factors. 
Traditional cardiovascular risk factors and antidepressant use accounted for a 
greater amount of the association between depression and MI, as evidenced by 
the risk associated with depressive disorders decreasing from 52% to 21% after 
full adjustment, and a smaller proportion of the association between depression 
and stroke (reduction in risk associated with depressive disorders from 40% to 
29%). 
Comparisons with existing literature
The associations between depressive disorders/anxiety and MI, and between 
depressive disorders and stroke confirm those of previous studies.(Dong et al., 
92012; Pan et al., 2014; Roest et al., 2010; Van der Kooy et al., 2007) While strong
evidence for a relationship between anxiety and fatal myocardial has been 
found, the evidence for a relationship with non-fatal MI is more equivocal.(Roest 
et al., 2010). Anxiety has been shown to increase risk of incident stroke in recent 
studies in a US setting.(Lambiase et al., 2014; Thurston et al., 2013) The lack of 
a relationship in our study may be due to lack of reliable assessment of anxiety, 
or the fact that we did not capture fatal events, and may have thus 
underestimated the relationship between anxiety and incident CVD.
The finding of increased cardiovascular risk amongst people with diagnosed 
depression reinforces that of recent studies: A 2014 meta-analysis of 28 cohort 
studies (n= 681,139) examining the risk of incident stroke in patients with 
depression reported a pooled estimate of 1.40 (CI95% 1.27-1.53) which aligns 
closely with the findings reported in above.(Barlinn and Kepplinger, 2015) Of the 
28 studies, two were based in the UK; the first reported no relationship between 
stroke and depression or anxiety, while the second reported a relationship 
between depression and coronary heart disease, but not stroke. (Surtees et al., 
2008)(Brunner et al., 2014)
Associations with antidepressant prescribing
The independent association between antidepressants and cardiovascular 
outcomes has been demonstrated before.(Pan et al., 2014) Clinical prescribing in
general practice is largely guided by evidence from randomized control trials, 
which tend to be conducted in idealized populations and have a short duration. 
In the absence of RCTs, the long term observation and follow-up of patients via 
routine electronic health databases will provide the timeliest evidence around 
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the benefits and risks of medication use in the general population.(Ayerbe et al., 
2014; Coupland et al., 2011) While we cannot infer causality from our 
observations, our results add to a significant body of evidence suggesting that 
antidepressants should be prescribed, balancing the benefits with the negative 
side effects associated with them in the long term. 
Strengths
Clinical data on anxiety and depression have been widely used for research 
purposes since large electronic databases have become available. Electronic 
health databases provide a platform to conduct high resolution research on very 
specific and clinically meaningful outcomes that are difficult to investigate with 
smaller cohorts. (Daskalopolou et al., 2016; Chou et al., 2012).The east London 
database covers a large, unselected, and geographically contiguous population, 
allowing for the capture of sufficient numbers of patients with the two most 
common psychiatric conditions to explore the relationship with cardiovascular 
outcomes. Given that 99% of the UK population is registered with a general 
practitioner, we are likely to have captured an accurate cross-section of the 
population of east London. The findings of this study can be generalized to other 
primary care populations in urban settings with high ethnic and social diversity.
The east London database captures all prescriptions issued by the general 
practice team. Though the database does not provide information on whether 
the prescriptions are filled, a comparison of prescribing data from electronic 
health databases and NHS dispensing data shows the two sources to be highly 
comparable, with 97% of cardiovascular medications dispensed as prescribed.
(The NHS Information Centre, 2011)
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The prospective nature of this study ensured that we captured incident 
cardiovascular events recorded after the onset of depression or anxiety, limiting 
the possibility of reverse causality. All data were entered into the medical record 
prospectively, minimizing the risk of recall bias or inaccurate self-report. The 
study accounted for the presence of well-established risk factors for 
cardiovascular disease and benefitted from high levels of ethnicity recording and 
patient level deprivation data, which allowed for a more accurate estimation of 
the independent effect of anxiety and depressive disorders on the CVD 
outcomes. This study has demonstrated that it is possible to replicate and 
confirm results from non-observational studies and trials in an electronic health 
database setting using observational epidemiology methodology. 
The capture and coding of both anxiety and depressive disorders is clearly 
outlined in the UK National Institute for Health and Care Excellence guidelines, 
and thus we expect that general practitioners will code this information 
consistently and to a high level. (NICE, 2014; NICE, 2011) Furthermore, incentive 
payments for the accurate recording of depression as part of the Quality and 
Outcomes Framework were introduced in 2006. A systematic review of the 
validity of diagnoses in the General Practice Research Database, which collects 
data identical to that used in our study has shown that 83% of cases with mental
and behavioural disorders present in the GPRD were confirmed by general 
practitioners. (Herrett et al., 2010)
Limitations
Anxiety and depressive disorders tend to be under-diagnosed in primary care 
settings. (Rait et al., 2009; Robert et al., 1997; Stein and Sareen, 2015) 
Furthermore, lower rates of healthcare usage amongst patients with these 
12
conditions may limit the opportunity to recognize major cardiovascular 
conditions in these populations.(Yeomans et al., 2014). 
The over diagnosis of depressive disorders, coupled with the under diagnosis of 
those who have depressive disorders but don't seek medical help due to reduced
motivation, may lead to an underestimation of the associations between 
depressive disorders and cardiovascular disease. (Mitchell et al., 2009) As a 
result, this study may have had reduced power to detect the true relationship 
between anxiety and depressive disorders and subsequent cardiovascular 
events. Furthermore, due to the nature of the data, we were unable to assess 
disease stage (for example, current, remitted, mild, moderate, severe), which 
could have an impact on the risk of incident cardiovascular disease. Data on 
physical activity were only available for 27.6% of the study sample and therefore
adjustment for this confounder was not possible.
The study included all patients currently registered in the database in 2015 and 
thus we did not have any patients that died during the course of follow-up. Lack 
of linkage to hospital episode statistics or mortality data meant that we were 
unable to examine all-cause mortality or CV related mortality in the study 
population.  Furthermore we were unable to determine whether any hospital 
admissions for MI or stroke had occurred prior to study entry, and thus we had to
assume that the first recorded event in the primary care database was truly 
incident. 
Though our study accounted for ever use of antidepressants, it did not take 
consider the dosage, drug type, or continuity of prescribing. The study also did 
not consider antipsychotic medication which has been shown to increase risk of 
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stroke, but not MI. (Brauer et al., 2011; Douglas and Smeeth, 2008)
We examined incidence of cardiovascular outcomes over the previous 10 years; 
this was due to confidence in the quality of the recorded covariate and diagnostic
data following the introduction of the Quality and Outcomes Framework in 2004, 
which rewarded general practices for high quality and complete recording of 
priority clinical conditions and risk factors across the UK.(NHS Employers, 2014)
We were unable to examine a “disease-free” cohort and follow them up 
prospectively to compare CVD outcomes between patients who developed 
anxiety/depression and those who did not. Furthermore, our use of baseline 
measures of key cardiovascular risk factors did not fully account for the time 
varying nature of risk factor control, which can change in response to both 
pharmacological and non-pharmacological intervention by the clinician, and in 
response to changes in morbidity status of the patient.
Unanswered questions and future research
Coded diagnoses for anxiety and depressive disorders do not provide any 
information as to the severity of the condition, which is likely to affect 
subsequent healthcare usage and cardiovascular risk. Using additional 
information to refine the classification of disease severity would improve the 
estimation of the independent effect of anxiety and depressive disorders on 
subsequent cardiovascular outcomes.(Kubzansky et al., 1998)
Small numbers of patients with diagnosed psychiatric conditions other than 
14
anxiety and depressive disorders meant that we were unable to extend the same
analysis to other relevant conditions such as those with schizophrenia, bipolar 
disorder, or personality disorders, which have been found to have a significant 
relationship with cardiovascular outcomes.(Ringen et al., 2014)  For the same 
reason, we were unable to estimate CV risk in individuals with more than one 
prevalent psychiatric condition at baseline. Conducting the analysis in larger or 
multiple electronic health databases would allow for the study of a wider range 
of psychiatric disorders would be valuable in confirming or refuting the findings, 
and also exploring risk in patients with concurrent anxiety and depressive 
disorders.
Clinical Relevance 
In conclusion, the evidence provided in this paper contributes to a better 
understanding of the association between anxiety and CVD, which has received 
little attention and confirms existing literature around the relationship between 
depression and MI/stroke. The weaker relationship between anxiety and excess 
risk of MI (after adjustment for traditional cardiovascular risk factors) is of clinical
importance and highlights that control of traditional risk factors is the 
cornerstone of cardiovascular disease prevention, even in populations with 
psychiatric disorders. Our findings suggest that strict control of cardiovascular 
risk factors among patients with anxiety disorders may reduce the risk of 
coronary or cerebrovascular events to a level equivalent to that for patients 
without anxiety. Our findings for depressive disorders suggest an independent 
effect of depression which persists despite accounting for cardiovascular risk 
factor control. Targeting more intensive management of cardiovascular risk 
factors and evaluating the benefit risk ratio of antidepressant prescribing should 
be prioritized amongst primary care teams.
15
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Figure 1. Cumulative Hazard Curves for incidence of MI and Stroke in patients with 
Anxiety or Depression
Table 1. Description of study sample
Whole
cohort
Anxiety
cohort
Non-Anxiety cohort p.val for
difference
Depression
cohort
Non-Depression
cohort
p.val for
difference
n (%) n (%) n (%) n (%) n (%)
N 524,952
(100)
22,128 (4.2) 502,824 (95.8) 21,811 (4.1) 503,141 (95.9)
Demographic characteristics at baseline
Mean age (SD) 35.9 (13.9) 42.7 (13.9) 35.6 (13.8) <0.001 43.2 (13.5) 35.6 (13.8) <0.001
Median age (IQR) 32 (25-44) 41 (32-52) 32 (24-43) 42 (33-52) 32 (24-43)
Female 247,528
(47.1)
13,267 (60.0) 234,261 (46.6) <0.001 13,777 (63.2) 233,751 (46.5) <0.001
Male 277,423
(52.8)
8,861 (40.0) 268,562 (53.4) 8034 (36.8) 269,389 (53.5)
White 220,079
(41.9)
13,863 (62.6) 206,216 (41.0) <0.001 13,436 (61.6) 206,643 (41.1) <0.001
South Asian 144,666
(25.6)
3,507 (15.8) 141,159 (28.1) 3,182 (14.6) 141,484 (28.1)
Black 89,186
(17.0)
2,739 (12.4) 86,447 (17.2) 3,155 (14.5) 86,031 (17.1)
Other 32,425 (6.2) 889 (4.0) 31,536 (6.3) 869 (4.0) 31,556 (6.3)
Unknown 38,596 (7.4) 1,130 (5.1) 37,466 (7.5) 1,169 (5.4) 37,427 (7.4)
Mean Townsend score (SD) 5.2 (1.8) 5.4 (1.8) 5.2 (1.8) <0.001 5.5 (1.7) 5.2 (1.8) <0.001
Prevalent cardiovascular risk factors and medication use at baseline
Diabetes mellitus 50,081 (9.5) 2,804 (12.7) 47,277 (9.4) <0.001 3,098 (14.20) 46,983 (9.3) <0.001
Current smoker 145,862
(27.8)
8,378 (37.9) 137,484 (27.3) <0.001 8,897 (40.8) 136,965 (27.2) <0.001
Hypertension 86,946
(16.6)
5,829 (26.3) 81,117 (16.1) <0.001 5,613 (25.7) 81,333 (16.2) <0.001
Hyperlipidemia (≥5 mmol/L) 204,682
(40.0)
13,223 (59.8) 191,459 (38.1) <0.001 13,392 (61.4) 191,290 (38.0) <0.001
Antidepressant use 125,532
(23.9)
15,228 (68.8) 110,304 (21.9) <0.001 16,659 (76.4) 108,873 (21.6) <0.001
Obesity (≥30 kg/m2) 36,195 (6.9) 3,417 (15.4) 32,778 (6.5) <0.001 3,791 (17.4) 32,404 (6.4) <0.001
Anxiety -- -- 5,132 (23.5) 16,996 (3.4) <0.001
Depression 5,132 (23.2) 16,679 (3.3) <0.001 -- --
Incident CVD 2005-2015
Incident MI 3,390 (0.7) 247 (1.1) 3,143 (0.6) <0.001 263 (1.2) 21,327 (0.6) <0.001
Mean age at first MI (SD) 59.5 (13.4) 58.5 (11.2) 61.2 (12.9)
Incident Stroke 987 (0.2) 68 (0.3) 919 (0.2) <0.001 79 (0.4) 908 (0.2) <0.001
Mean age at first Stroke 
(SD)
61.6 (15.3) 63.4 (12.7) 59.2 (13.0)
*Comparisons between patients with/without anxiety and with/without depression were made using t-tests for continuous variables, and from chi-squared test for 
unordered categorical variables
Table 2. Association between anxiety and MI/Stroke (n=524,916) 
Risk of MI Risk of Stroke
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Anxiety at baseline 1.33*** [1.17,1.52]
1.10 [0.96,1.2
6]
1.08 [0.94,1.2
4]
1.17 [0.91,1.5
1]
1.09 [0.84,1.4
1]
1.06 [0.81,1.3
8]
Age 1.07*** [1.07,1.08]
1.07*** [1.07,1.0
7]
1.07*** [1.07,1.0
7]
1.08*** [1.07,1.0
8]
1.07*** [1.07,1.0
8]
1.07*** [1.07,1.0
8]
Gender
   Female (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   Male 2.87*** [2.66,3.10]
2.82*** [2.61,3.0
5]
2.84*** [2.62,3.0
6]
1.43*** [1.26,1.6
2]
1.43*** [1.26,1.6
3]
1.44*** [1.26,1.6
3]
Ethnic Group
   White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   South Asian 1.86*** [1.71,2.02]
1.86*** [1.71,2.0
3]
1.87*** [1.72,2.0
4]
1.24* [1.04,1.4
8]
1.18 [0.99,1.4
2]
1.19 [1.00,1.4
3]
   Black African/Caribbean 0.52*** [0.46,0.59]
0.51*** [0.45,0.5
7]
0.51*** [0.45,0.5
8]
1.40*** [1.19,1.6
5]
1.29** [1.09,1.5
2]
1.29** [1.09,1.5
3]
   Other ethnic group 0.76** [0.63,0.92]
0.81* [0.68,0.9
8]
0.82* [0.68,0.9
9]
1.09 [0.80,1.4
9]
1.10 [0.80,1.5
0]
1.10 [0.81,1.5
1]
Hypertension 1.17*** [1.07,1.28]
1.17*** [1.07,1.2
8]
1.47*** [1.25,1.7
3]
1.47*** [1.25,1.7
3]
Diabetes Mellitus 1.48*** [1.33,1.63]
1.48*** [1.33,1.6
3]
1.46*** [1.21,1.7
5]
1.46*** [1.21,1.7
5]
Hyperlipidemia 1.12* [1.02,1.22]
1.12* [1.02,1.2
2]
0.89 [0.75,1.0
5]
0.89 [0.75,1.0
5]
Current smoker 2.03*** [1.87,2.20]
2.02*** [1.86,2.1
9]
1.33** [1.12,1.5
9]
1.33** [1.11,1.5
8]
Antidepressant use 1.25*** [1.13,1.39]
1.20*** [1.08,1.3
4]
1.07 [0.87,1.3
0]
1.01 [0.82,1.2
4]
Townsend deprivation 
score
1.06*** [1.04,1.0
9]
1.06*** [1.04,1.0
8]
1.03 [0.99,1.0
7]
1.03 [0.99,1.0
7]
Obesity 1.73*** [1.60,1.8
7]
1.73*** [1.60,1.8
7]
1.45*** [1.25,1.6
8]
1.45*** [1.25,1.6
8]
Depression 1.21** [1.05,1.3
9]
1.29 [1.00,1.6
6]
* Columns display hazard ratio, and 95% confidence interval, *p<0.05 **p<0.01 ***p<0.0001, all models account for clustering by general practice. 
Table 3. Association between depressive disorders and MI/Stroke (n=524,916) 
Risk of MI Risk of Stroke
Model 1 Model 2 Model 3 Model1 Model2 Model 3
Depression at baseline 1.52***
[1.34,1.73] 1.22*** [1.06,1.40] 1.21** [1.05,1.39
]
1.40** [1.11,1.78] 1.29* [1.00,1.6
7]
1.29 [1.00,1.66]
Age 1.07***
[1.07,1.08] 1.07*** [1.07,1.07] 1.07**
*
[1.07,1.07
]
1.08**
*
[1.07,1.08] 1.07*** [1.07,1.0
8]
1.07*** [1.07,1.08]
Gender
   Female (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   Male 2.89***
[2.68,3.12] 2.83*** [2.62,3.06] 2.84**
*
[2.62,3.06
]
1.44**
*
[1.27,1.63] 1.43*** [1.26,1.6
3]
1.44*** [1.26,1.63]
Ethnic Group
   White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   South Asian 1.87***
[1.72,2.03] 1.87*** [1.72,2.04] 1.87**
*
[1.72,2.04
]
1.25* [1.05,1.49] 1.19 [1.00,1.4
3]
1.19 [1.00,1.43]
   Black African/Caribbean 0.52***
[0.46,0.59] 0.51*** [0.45,0.58] 0.51**
*
[0.45,0.58
]
1.41**
*
[1.20,1.66] 1.29** [1.09,1.5
3]
1.29** [1.09,1.53]
   Other ethnic group 0.77** [0.64,0.92] 0.82* [0.68,0.98] 0.82* [0.68,0.99]
1.10 [0.80,1.50] 1.10 [0.81,1.5
1]
1.10 [0.81,1.51]
Hypertension 1.17*** [1.07,1.28] 1.17***
[1.07,1.28
]
1.47*** [1.25,1.7
3]
1.47*** [1.25,1.73]
Diabetes Mellitus 1.47*** [1.33,1.63] 1.48***
[1.33,1.63
]
1.45*** [1.21,1.7
5]
1.46*** [1.21,1.75]
Hyperlipidemia 1.12* [1.02,1.22] 1.12* [1.02,1.22]
0.89 [0.75,1.0
5]
0.89 [0.75,1.05]
Current smoker 2.02*** [1.86,2.19] 2.02***
[1.86,2.19
]
1.33** [1.12,1.5
8]
1.33** [1.11,1.58]
Antidepressant use 1.22*** [1.10,1.35] 1.20***
[1.08,1.34
]
1.02 [0.83,1.2
5]
1.01 [0.82,1.24]
Townsend deprivation 
score
1.06*** [1.04,1.08] 1.06**
*
[1.04,1.08
]
1.03 [0.99,1.0
7]
1.03 [0.99,1.07]
Obesity 1.73*** [1.60,1.87] 1.73**
*
[1.60,1.87
]
1.45*** [1.25,1.6
8]
1.45*** [1.25,1.68]
Anxiety 1.08 [0.94,1.24
]
1.06 [0.81,1.38]
* Columns display hazard ratio, and 95% confidence interval, *p<0.05 **p<0.01 ***p<0.0001, all models account for clustering by general practice. 
Table 4. Age at first presentation of MI and Stroke 
Difference in age at presentation (years)
MI Coefficient CI95% p.va;
Anxiety -3.6 -5.0 – -2.1 <0.001
Depression -1.0 -2.5 – 0.5 0.203
Stroke
Anxiety 0.5 -2.7 – 3.7 0.736
Depression -4.1 -7.1 – -1.1 0.008
**All models adjusted for gender and ethnic group, and clustering by general practice
Highlights
• The study finds strong evidence for an independent association between 
depression and cardiovascular events, and weaker evidence for an association 
with anxiety.
• Mean age at first MI is lower in those with anxiety compared to those without 
anxiety, while mean age at first stroke is lower in those with depression 
compared to those without depression. 
• The study shows an independent effect of antidepressant prescribing on risk of 
MI, but not stroke. 
• The findings highlight that that control of traditional risk factors is the 
cornerstone of cardiovascular disease prevention in populations with psychiatric 
conditions.
• Targeting intensive management of classical cardiovascular risk factors and 
evaluating the benefit risk ratio of antidepressant prescribing should be 
prioritized amongst primary care teams.
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